Drug-drug interactions: proof of relevance (part I).
Preskorn
Sheldon H
SH
Department of Psychiatry, University of Kansas School of Medicine-Wichita, and Clinical Research Institute, Wichita, Kansas, USA.
D000900:Anti-Bacterial Agents / Q000378:metabolism; D000935:Antifungal Agents / Q000378:metabolism; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000493:pharmacokinetics*; D021983:Cyclophilins / Q000187:drug effects; D004347:Drug Interactions; D064420:Drug-Related Side Effects and Adverse Reactions; D004917:Erythromycin / Q000378:metabolism; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced; D001523:Mental Disorders / Q000188:drug therapy*; D008795:Metronidazole / Q000378:metabolism
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D014150:Antipsychotic Agents; D008795:Metronidazole; D004917:Erythromycin; D021983:Cyclophilins; C102923:PPIG protein, human